TCR2 THERAPEUTICS INC. Quarterly Return On Equity in % from Q4 2018 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tcr2 Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Return On Equity for the quarter ending March 31, 2023 was -97.8 %, a 167% decline year-over-year.
  • Tcr2 Therapeutics Inc. annual Return On Equity for 2022 was -74 %, a 135% decline from 2021.
  • Tcr2 Therapeutics Inc. annual Return On Equity for 2021 was -31.5 %, a 9.71% increase from 2020.
  • Tcr2 Therapeutics Inc. annual Return On Equity for 2020 was -34.9 %, a 29.5% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -97.8 -61.2 -167% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74 -42.5 -135% Oct 1, 2022 Dec 31, 2022
Q3 2022 -49.5 -19.9 -67.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -42.9 -15.1 -54.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.7 -6.57 -21.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.5 +3.39 +9.71% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.6 +5.86 +16.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -27.8 +10.4 +27.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.1 +2.11 +6.55% Jan 1, 2021 Mar 31, 2021
Q4 2020 -34.9 -7.96 -29.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -35.5 +1.4 +3.79% Jul 1, 2020 Sep 30, 2020
Q2 2020 -38.2 +27.3 +41.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -32.2 -489 -107% Jan 1, 2020 Mar 31, 2020
Q4 2019 -27 -64.4 -172% Oct 1, 2019 Dec 31, 2019
Q3 2019 -36.9 Jul 1, 2019 Sep 30, 2019
Q2 2019 -65.5 Apr 1, 2019 Jun 30, 2019
Q1 2019 457 Jan 1, 2019 Mar 31, 2019
Q4 2018 37.4 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.